Viral Dynamics of Acute HIV-1 Infection
暂无分享,去创建一个
Douglas D. Richman | Angela R. McLean | Celsa A. Spina | Diane V. Havlir | D. Richman | S. Little | A. McLean | D. Havlir | C. Spina | Susan J. Little
[1] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[2] J. Gerberding,et al. The Care of Persons with Recent Sexual Exposure to HIV , 1998, Annals of Internal Medicine.
[3] D. Cooper,et al. Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. Sydney Primary HIV Infection Study Group. , 1997, The Journal of infectious diseases.
[4] L M Wahl,et al. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection , 1997, Journal of virology.
[5] J. Gold,et al. ACUTE AIDS RETROVIRUS INFECTION Definition of a Clinical Illness Associated with Seroconversion , 1985, The Lancet.
[6] A S Perelson,et al. Rate of HIV‐1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen , 1998, AIDS.
[7] P. Kahn. Susceptibility Genes: Pointing a Way to Prevention? , 1996, Science.
[8] D. Cardo,et al. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood--France, United Kingdom, and United States, January 1988-August 1994. , 1995, MMWR. Morbidity and mortality weekly report.
[9] D. Richman,et al. Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. , 1997, The Journal of clinical investigation.
[10] M A Nowak,et al. Virus dynamics and drug therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[11] D. Richman,et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.
[12] S. J. Clark,et al. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. , 1991, The New England journal of medicine.
[13] T. Elbeik,et al. Activation of virus replication after vaccination of HIV-1-infected individuals , 1995, The Journal of experimental medicine.
[14] D. Ho,et al. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. , 1991, The New England journal of medicine.
[15] E. Rosenberg,et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. , 1997, Science.
[16] J. Lisziewicz,et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy , 1999, Nature Medicine.
[17] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[18] D. Montefiori,et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.
[19] D. Richman,et al. Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells , 1990, Journal of virology.
[20] Andrew N. Phillips,et al. Reduction of HIV Concentration During Acute Infection: Independence from a Specific Immune Response , 1996, Science.
[21] F. McCutchan,et al. Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. , 1993, The New England journal of medicine.
[22] M. Stevenson,et al. HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.
[23] J. Justement,et al. Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[24] G. Macdonald,et al. The analysis of equilibrium in malaria. , 1952, Tropical diseases bulletin.
[25] R Brookmeyer,et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.
[26] K. Harada,et al. Direct Observation of Vortex Dynamics in Superconducting Films with Regular Arrays of Defects , 1996, Science.
[27] D. Baltimore,et al. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression , 1989, Journal of virology.
[28] M. Hirsch,et al. Primary human T-lymphotropic virus type III infection. , 1985, Annals of internal medicine.
[29] P D Griffiths,et al. Population dynamics of HIV within an individual after treatment with zidovudine , 1991, AIDS.
[30] J. Mellors,et al. Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion , 1995, Annals of Internal Medicine.
[31] V. Calvez,et al. HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group. , 1999, AIDS.
[32] J. Kaldor,et al. Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year. Sydney Primary HIV Infection Study Group. , 1996, The Journal of infectious diseases.
[33] D. Richman,et al. Cell-associated viral RNA expression during acute infection with HIV type 1. , 1998, AIDS research and human retroviruses.
[34] J. Mcdougal,et al. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. , 1985, Journal of immunology.
[35] J. Goedert,et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. , 1996, JAMA.
[36] A. Panlilio,et al. Public Health Service Guidelines for the Management of Health-Care Worker Exposures to HIV and Recommendations for Postexposure Prophylaxis. Vol. 47/No. RR-7. , 1998 .